Company Filing History:
Years Active: 2025
Title: Ho Joon Park: Innovator in Pharmaceutical Science
Introduction
Ho Joon Park is a notable inventor based in South Korea, recognized for his contributions to pharmaceutical science. His work primarily focuses on the development of novel compounds that enhance drug efficacy and absorption.
Latest Patents
One of his significant inventions is the "Novel Rebamipide Prodrugs Compound, And Preparation Method Thereof." This patent discloses a novel rebamipide prodrug, a method for preparing it, and its various uses. The rebamipide prodrug exhibits a remarkable 25-fold increase in absorption rate compared to rebamipide itself. This advancement has potential applications in the prophylaxis or therapy of several medical conditions, including gastric ulcers, acute gastritis, chronic gastritis, xerophthalmia, cancer, osteoarthritis, rheumatoid arthritis, and obesity.
Career Highlights
Throughout his career, Ho Joon Park has focused on innovative approaches to drug formulation and delivery. His research has contributed significantly to the field of pharmacology, particularly in enhancing the therapeutic effects of existing medications.
Collaborations
Ho Joon Park has collaborated with esteemed colleagues, including Eui-Hwan Cho and Sung Ju Choi, to further advance his research and development efforts.
Conclusion
Ho Joon Park's innovative work in developing novel pharmaceutical compounds demonstrates his commitment to improving healthcare outcomes. His contributions to the field of drug development are noteworthy and have the potential to impact various medical conditions significantly.